Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma

Song, An; Wu, Yuanyuan; Chu, Weiming; Yang, Xueming; Zhu, Zaiou; Yan, Enshi; Zhang, Wei; Zhou, Junbo; Ding, Xu; Liu, Jie; Zhu, Hongxia; Ye, Jinhai; Wu, Yunong; Zheng, Yang; Song, Xiaomeng

doi:10.7150/ijbs.54014



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2021; 17(2):430-447. doi:10.7150/ijbs.54014 This issue Cite

Research Paper

Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma

An Song^1,2, Yuanyuan Wu^1,2, Weiming Chu^1,3, Xueming Yang^1,4, Zaiou Zhu^1,2, Enshi Yan⁵, Wei Zhang¹, Junbo Zhou⁶, Xu Ding^1,2, Jie Liu^1,2, Hongxia Zhu^1,2, Jinhai Ye^1,2, Yunong Wu^1,2, Yang Zheng^1,2✉, Xiaomeng Song^1,2✉

1. Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
2. Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
3. Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China.
4. Department of Stomatology, the Affiliated People's Hospital of Jiangsu University, Zhenjiang 21200, Jiangsu Province, China.
5. Department of Anesthesiology, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China.
6. Department of Stomatology, Nanjing Integrated Traditional Chinese and Western Medicine Hospital, Nanjing, Jiangsu, People's Republic of China.

✉ Corresponding authors: Professor Xiaomeng Song, Key Laboratory of Oral Diseases of Jiangsu Province and Stomatological Institute of Nanjing medical University, No.1, Shanghai Road, Gulou District, Nanjing, Jiangsu, 210029 China; Tel: 86-25-69593100; More

Citation:

Song A, Wu Y, Chu W, Yang X, Zhu Z, Yan E, Zhang W, Zhou J, Ding X, Liu J, Zhu H, Ye J, Wu Y, Zheng Y, Song X. Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma. Int J Biol Sci 2021; 17(2):430-447. doi:10.7150/ijbs.54014. https://www.ijbs.com/v17p0430.htm

Other styles

Abstract

MicroRNAs are major post-transcriptional regulators responsible for the development of human cancers, including OSCC. The specific role of miR-619-5p in OSCC, however, is rarely reported. Cisplatin is one of the mostly applied chemotherapy drugs of OSCC. Nevertheless, drug resistance of cisplatin following the initial chemotherapy largely restricts its clinical benefits, and the mechanism of cisplatin resistance is unclear. This study intends to explore the biological function of miR-619-5p in the development of cisplatin resistance in OSCC cell lines and a xenograft model, as well as the potential molecular mechanism. Our results showed that miR-619-5p was down-regulated in OSCC samples and cisplatin-resistant OSCC cells. Ectopically expressed miR-619-5p inhibited proliferative, migratory and invasive abilities of OSCC cisplatin-resistant cells. The putative target gene ATXN3 was predicted by bioinformatic analysis and confirmed by dual-luciferase reporter assay. Importantly, ATXN3 was responsible for the regulatory effects of miR-619-5p on biological behaviors of cisplatin-resistant OSCC cells. Moreover, miR-619-5p mimics and ATXN3-siRNA significantly enhanced ATXN3 knockdown in both HN6/CDDPR and CAL27/CDDPR cells and inhibited expression of PI3K and AKT. In vivo evidences demonstrated that intratumoral injection of miR-619-5p agomir remarkably slowed down the growth of OSCC in xenograft mice. Collectively, microRNA-619-5p was the vital regulator for regulating cisplatin resistance of OSCC, which may be served as a potential therapeutic target.

Keywords: OSCC, miR-619-5p, cisplatin-resistance, ATXN3

Citation styles

APA

Song, A., Wu, Y., Chu, W., Yang, X., Zhu, Z., Yan, E., Zhang, W., Zhou, J., Ding, X., Liu, J., Zhu, H., Ye, J., Wu, Y., Zheng, Y., Song, X. (2021). Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma. International Journal of Biological Sciences, 17(2), 430-447. https://doi.org/10.7150/ijbs.54014.

ACS

Song, A.; Wu, Y.; Chu, W.; Yang, X.; Zhu, Z.; Yan, E.; Zhang, W.; Zhou, J.; Ding, X.; Liu, J.; Zhu, H.; Ye, J.; Wu, Y.; Zheng, Y.; Song, X. Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma. Int. J. Biol. Sci. 2021, 17 (2), 430-447. DOI: 10.7150/ijbs.54014.

NLM

CSE

Song A, Wu Y, Chu W, Yang X, Zhu Z, Yan E, Zhang W, Zhou J, Ding X, Liu J, Zhu H, Ye J, Wu Y, Zheng Y, Song X. 2021. Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma. Int J Biol Sci. 17(2):430-447.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.